相关实验视频
Updated: Jan 8, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
概括
免疫球蛋白基因表达特异性不仅仅由增强剂控制. 促进体和内基序列中的新调节区域也确保了淋巴细胞特异性基因转录.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 免疫球蛋白 (Ig) 重 (H) 基因表达对B细胞功能至关重要.
- 了解Ig基因调节的细胞类型特异性对于免疫系统研究至关重要.
研究的目的:
- 研究控制免疫球蛋白重链 (IgH) 基因表达的细胞类型特异性的调控因素.
- 为了确定IgH增强剂之外的新型调节区域,参与组织特异性Ig基因转录.
主要方法:
- 构建混合基因,将Ig基因序列与组织非特异性转录单元结合起来.
- 将这些混合基因引入淋巴细胞和非淋巴细胞以进行表达分析.
- 用病毒增强剂取代IgH增强剂,以评估其对组织特异性的影响.
主要成果:
- 用病毒增强剂替换淋巴细胞特异性IgH增强剂并没有改变MuIg基因表达的组织特异性.
- 确定了一个VH促进器区域 (-154到+57),即使使用病毒增强剂,也可指导淋巴细胞特异转录.
- 发现没有IgH增强剂的mu内基序列以组织特定的方式调节转录水平.
结论:
- Ig基因表达的组织特异性受到多种因素的调节,而不仅仅是增强剂.
- 维H促进体和内基序列含有关键的淋巴细胞特异性调控信息.
- 这些发现扩大了我们对控制B淋巴细胞Ig基因调节的复杂机制的理解.
相关概念视频
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K